LATEST ALERTS
Altria has disclosed in a filing to the US Securities and Exchange Commission (SEC) that it is ending its non-compete agreement with Juul
The US Food and Drug Administration (FDA)’s Center for Tobacco Products (CTP) has launched an online resource centre providing science-based, standards-mapped materials that teachers can use to help their students understand the dangers of vaping and nicotine addiction
Tobacco companies still have some work to do to meet commitments in offering reduced risk alternatives – and when they do, it’s often focused elsewhere than the vaping category
Juul Labs is asking a judge to order the US Food and Drug Administration (FDA) to release information related to its now-vacated denial of the company’s premarket tobacco application (PMTA), calling the withholding of material “part of a troubling pattern of decreasing transparency at the agency”
US politicians and public health associations have broadly welcomed Juul Labs’ $438.5m settlement, which ended a two-year investigation by 34 US states into the e-cigarette maker’s marketing and sales practices
The Brazilian Ministry of Justice has written to 32 companies ordering them to cease the sale of vaping products in the country
US scientists need to communicate more effectively with politicians and the public to ensure the country overcomes a prohibitionist mindset on tobacco harm reduction, according to some public health experts
The early legal success of the vaping company Gripum against the US Food and Drug Administration (FDA) over its marketing denial order (MDO) has given way to a major defeat
New and emerging nicotine and tobacco products such as e-cigarettes are becoming increasingly available in the Americas and now pose a threat to the progress of tobacco control, a new report says
Juul Labs has agreed to a $438.5m settlement, ending a two-year investigation by 34 US states into its marketing and sales practices
Prohibition Juice has failed in an attempt to get the US Food and Drug Administration (FDA)’s authority over vaping products curtailed
In a big win for the vaping industry, a federal appellate court has ordered the US Food and Drug Administration (FDA) to reconsider its denial of premarket tobacco product applications (PMTAs) for six companies
Alaska will face an additional excise tax on vaping products but will not face a flavour ban after the state’s legislature finalised the passage of Senate Bill 45 (SB45) and transmitted it to the governor’s office
Cristine Delnevo, the new chair of the US FDA’s Tobacco Products Scientific Advisory Committee (TPSAC), has been hailed as an “objective, thoughtful scientist” with an understanding of research into harm reduction
Vaping industry representatives have accused the US Food and Drug Administration (FDA) of “creating a fake panic” with a warning over illegal flavoured nicotine gummies
The Democratic governor of Hawaii appeared to take a step out of line with the US party’s common position when he vetoed a bill that would have introduced a ban on flavoured tobacco and vaping products
A potentially key but temporary legal win for a vaping company challenging the US Food and Drug Administration (FDA)’s PMTA review process has been transformed into a resounding loss
Turning Point Brands has blamed the hostile regulatory environment for vapour products in the US for the lowering of its sales and revenue expectations for 2022
Uncertainty is mounting over the US Food and Drug Administration (FDA)’s premarket tobacco application (PMTA) process after the agency shifted its position on Juul Labs’ application, leading to searching questions
Altria is pessimistic about the future of Juul and its investment in the company but does not think the time has come to pull the plug just yet
British American Tobacco (BAT) enjoyed a 45% rise in revenue from its new products category in the first half of the year, with strong momentum shown by its Vuse e-cigarette range
The vaping industry has little faith that the upcoming external review of the Center for Tobacco Products (CTP) will help fix faults in the US FDA department’s regulation of new tobacco and alternative products
Philip Morris International (PMI) will continue to support the sales and promotion of its Iqos Veev vapour product as part of its commitment to expanding its smoke-free product portfolio
Myblu vaping products will not be allowed to be sold in the US market while a court reviews a marketing denial order (MDO)
US Food and Drug Administration (FDA) commissioner Robert Califf has authorised an external review of the Center for Tobacco Products (CTP), citing a “series of challenges that have…stressed the agency’s operations”
Arguments in a US appeal court could demonstrate how judges are likely to perceive arguments from vaping companies contesting US Food and Drug Administration (FDA) decisions on pre-market tobacco applications (PMTAs)
The US Food and Drug Administration (FDA) took immediate action against unauthorised vaping products made with synthetic nicotine still found on the US market after the grace period expired
E-cigarettes will almost certainly remain banned in Brazil following a unanimous vote by the board of Anvisa, the country’s health agency
The number of US adults who think e-cigarettes are more harmful than traditional tobacco products has effectively doubled year on year from 2018 to 2020, according to new research – and that has affected smoking rates
The US Food and Drug Administration (FDA) has temporarily suspended the marketing denial order (MDO) it served on Juul Labs last month demanding the company remove its e-cigarettes from the US market
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
